Chargement en cours...
Ocrelizumab: a new milestone in multiple sclerosis therapy
B cells play a central role in the pathogenesis of multiple sclerosis (MS): they are involved in the activation of pro-inflammatory T cells, secretion of pro-inflammatory cytokines and production of autoantibodies directed against myelin. Hence, the use of B cell-depleting monoclonal antibodies as t...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publishing
2018-05-01
|
| Collection: | Therapeutic Advances in Neurological Disorders |
| Accès en ligne: | https://doi.org/10.1177/1756286418773025 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|